Novartis’ Enablex To Enter Crowded Urinary Incontinence Market In Early ‘05
Novartis plans to enter the urinary incontinence market in early 2005 with the launch of its newly approved overactive bladder therapy Enablex
Novartis plans to enter the urinary incontinence market in early 2005 with the launch of its newly approved overactive bladder therapy Enablex